ZERIA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,119 JPY | +1.00% |
|
+3.01% | +5.06% |
| Apr. 23 | Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints | CI |
| Feb. 16 | Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3 | MT |
Evolution of the average Target Price on Zeria Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
498948bc3ecd124ddd2f841cd1520.vGnO3uI6CfcyCr8MT9s6VDfTM8ro7-wIaauvVo4K6-o.0ji96olMJL9cS896DJwKB36GZ4KtldR6AdL3L75JpZyRAbeUjlx5xGE73A~04131846832afb21183e54b32ea50aaf
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2,098
JPY
Average target price
2,810
JPY
Spread / Average Target
+33.94%
High Price Target
2,810
JPY
Spread / Highest target
+33.94%
Low Price Target
2,810
JPY
Spread / Lowest Target
+33.94%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4559 Stock
- Consensus Zeria Pharmaceutical Co., Ltd.
